Brian A. Ratner
Brian Ratner is a Partner at Hausfeld and Head of the firm’s International practice. He also serves on the firm’s Management Committee and leads the firm’s global business development efforts. Brian has extensive experience representing U.S. and international businesses in complex litigation at the trial and appellate levels. He is particularly experienced in litigating and resolving antitrust claims in U.S. and European courts, recovering hundreds of millions of dollars for his corporate clients.
Brian’s broad experience demonstrates his ability to tackle and find solutions for the most novel legal issues, as well as represent his clients at all stages of global antitrust litigation and other complex business disputes, whether in the discovery, damages, trial, appeal or settlement phase, or whether in the U.S., Europe, or globally. This unique combination enables him to counsel and act for clients comprehensively, in a commercially sensitive manner, and wherever necessary.
Brian was selected to the Washington, DC Super Lawyers list for 2014, 2015, 2016, and 2017. For the past 5 years, The Legal 500, which provides comprehensive worldwide coverage on legal services and rankings, selected Brian as one of the Leading Lawyers in the U.S. representing plaintiffs in antitrust matters, stating that the “‘incredibly impressive . . . Michael Hausfeld and Brian Ratner are highly skilled negotiators and litigators, and real fighters with an outstanding strategic sense . . . brilliant lawyer Brian Ratner is a very smart and business-oriented negotiator’ . . . [He] thinks strategically, is an excellent negotiator and has a solid foundation of substantive law.” In 2011, the publication also recommended him as an “engaging, highly competent professional who can simplify complex antitrust matters and make them comprehensible to a non-antitrust attorney.” Brian was named to the 2018 Lawdragon 500 Leading Lawyers in America list and the 2018 Who’s Who Legal: Competition list. The Benchmark Plaintiff Guide to America's Leading Plaintiff's Firms and Attorneys, named Brian as one of the country’s top “Antitrust Litigation Stars” in 2013, and as one of Washington, DC’s “Local Litigation Stars” from 2013-2015. Brian was also honored by Law360 as one of its 2012 Rising Stars and was previously named to the Legal Times 2009 "40 under 40" list, which recognized rising legal stars expected to play a key role in the Greater Washington legal community for years to come.
Brian has successfully litigated some of the biggest, most challenging, and most high stakes antitrust litigation in U.S. federal courts. He served as one of the lead lawyers in the landmark Vitamins Antitrust Litigation (D.D.C.) on behalf of vitamin direct purchasers who were overcharged as a result of a ten-year global price-fixing and market allocation conspiracy. The case settled for over $1 billion and included a 2003 jury trial resulting in a verdict of $148 million in trebled damages - the twelfth largest U.S. jury verdict in 2003. Brian was one of the principal lawyers that led the related case of Empagran, S.A. et al. v. F. Hoffmann-LaRoche, Ltd., et al. (D.D.C.), on behalf of foreign vitamin purchasers, all the way to the Supreme Court, resulting in a groundbreaking judgment on the scope of U.S. Sherman Act jurisdiction. This case was designated as the "Matter of the Year" by the Global Competition Review. Brian has also litigated, among other matters: In re Vitamin C Antitrust Litigation (E.D.N.Y.), a case alleging a conspiracy to fix the price and limit the supply of Vitamin C sold for export to the United States, which has resulted in entry of a 2013 judgment for $153.3 million post jury verdict in the direct purchasers' favor - the thirteenth largest U.S. jury verdict in 2013 - and $32.5 million in settlements to date; Oncology & Radiation Associates v. Bristol-Myers Squibb Co. (D.D.C.), a case alleging unlawful monopolization against a drug manufacturer, which settled for $65 million; and Molecular Diagnostics Laboratories v. Hoffmann-La Roche, Inc., et al. (D.D.C.), a case alleging unlawful monopolization on behalf of purchasers of an enzyme used in DNA amplification, human-genome research, and medical diagnostics, which settled for $33 million. Brian also serves as one of the lead lawyers representing the class in In re American Express Anti-Steering Rules Antitrust Litigation (E.D.N.Y.) and acted on the defense side in a U.S. class action against freight forwarders alleging a conspiracy to fix surcharges on air cargo shipments.
In coordination with his UK partners, Brian also currently represents purchasers of auto parts, car glass, polyurethane foam, air freight services, Visa/MasterCard services, trucks, power cables, carbon graphite, elevators, and pre-stressing steel in their individual cartel damage claims in Europe. Several of these clients are listed in Fortune Global 500 and Forbes Global 2000. Additionally, in the marine hose matter, on behalf of a group of oil and gas companies, he led the negotiations with cartelist Parker ITR which produced a first of its kind private global settlement agreement.
Brian has also frequently lectured, published articles and papers, and organized conferences on issues such as the private civil enforcement of competition law and the mechanisms for collective redress around the world.
Disclaimer: The DC Super Lawyers list is issued by Thomson Reuters; a description of the selection methodology can be found here. The Legal 500 is published by Legalease Ltd; a description of the selection methodology can be found here. The Benchmark Plaintiff Guide is published by Euromoney Institutional Investor PLC and Institutional Investor, Inc.; a description of the selection methodology can be found here. The Law360 Rising Stars list is issued by Portfolio Media, Inc.; a description of the selection methodology can be found here. The Legal Times “40 under 40” list is issued by American Lawyer Media; a description of the selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.